Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors
Clinical trial NCT03644056 · COMPLETED
Trial details
- NCT number
- NCT03644056
- Sponsor
- ImmuneOncia Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-22
- Primary completion
- 2019-02-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.